Show simple item record

dc.contributor.authorTreacy, Maxwell P
dc.contributor.authorHurst, Tara P
dc.date.accessioned2013-04-24T11:45:26Z
dc.date.available2013-04-24T11:45:26Z
dc.date.issued2012-09
dc.identifier.citationThe case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy. 2012, 12:46 BMC Ophthalmolen_GB
dc.identifier.issn1471-2415
dc.identifier.pmid22937835
dc.identifier.doi10.1186/1471-2415-12-46
dc.identifier.urihttp://hdl.handle.net/10147/283772
dc.description.abstractSystemic therapeutics targeting the peroxisome proliferator-activated receptors have been found to be beneficial in the treatment of diabetic retinopathy. In this paper, we provide a rationale for the use of these therapeutics as intraocular agents. In addition, we introduce the peroxisome proliferator-activated receptors and describe their functions in response to the drugs.
dc.language.isoenen
dc.relation.urlhttp://www.biomedcentral.com/content/pdf/1471-2415-12-46.pdfen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532122/pdf/1471-2415-12-46.pdfen_GB
dc.rightsArchived with thanks to BMC ophthalmologyen_GB
dc.subject.meshDiabetic Retinopathy
dc.subject.meshEye
dc.subject.meshFenofibrate
dc.subject.meshHumans
dc.subject.meshHypolipidemic Agents
dc.subject.meshInjections
dc.subject.meshPPAR alpha
dc.subject.meshTreatment Outcome
dc.titleThe case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy.en_GB
dc.typeArticleen
dc.contributor.departmentRoyal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Dublin, Ireland. max@treacy.ieen_GB
dc.identifier.journalBMC ophthalmologyen_GB
dc.description.provinceLeinsteren
refterms.dateFOA2023-09-13T16:11:33Z
html.description.abstractSystemic therapeutics targeting the peroxisome proliferator-activated receptors have been found to be beneficial in the treatment of diabetic retinopathy. In this paper, we provide a rationale for the use of these therapeutics as intraocular agents. In addition, we introduce the peroxisome proliferator-activated receptors and describe their functions in response to the drugs.


Files in this item

Thumbnail
Name:
1471-2415-12-46.pdf
Size:
279.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record